Sai Parenterals Limited (SAIPARENT) — deviation variation | 23 May 2026

StockFin.ai

Try Free

Sai Parenterals Limited disclosed no deviation or variation in the utilization of IPO proceeds for the quarter and year ended March 31, 2026, confirming all funds were applied to original objectives including capacity expansion, R&D center establishment, debt repayment, working capital, bridge loan repayment, and general corporate purposes without any material changes.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SAIPARENT ✨ Ask AI About This

About Sai Parenterals Limited (SAIPARENT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,126.13 Cr

View full SAIPARENT stock details →

📡 Get AI alerts when SAIPARENT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAIPARENT — Free

💡 Ask AI about this filing

"How does this deviation variation affect Sai Parenterals Limited's outlook?" "What did Sai Parenterals Limited announce on 23 May 2026?" "Is this positive or negative for SAIPARENT?"

Ask AI Free →

📊 More SAIPARENT filings

See all SAIPARENT filings →

🔥 Also filed on 23 May 2026

PRITIKAUTO Pritika Auto Industries Limited Financial Results QUICKHEAL Quick Heal Technologies Limited Financial Results PTC PTC India Limited Announcement PTC PTC India Limited Financial Results PVSL Popular Vehicles and Services Limited Financial Results RAINBOW Rainbow Childrens Medicare Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SAIPARENT files new disclosures

Track SAIPARENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAIPARENT — Free

Free account · 2 AI queries/day